Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Discovery of Potent Cholinesterase Inhibition-Based Multi-Target-Directed Lead Compounds for Synaptoprotection in Alzheimer’s Disease
Bengisu Turgutalp, Prabesh Bhattarai, Tuğba Erçeti̇n, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 18, pp. 12292-12318
Closed Access | Times Cited: 20

Showing 20 citing articles:

Sigma-2 Receptors—From Basic Biology to Therapeutic Target: A Focus on Age-Related Degenerative Diseases
Britney N. Lizama, Jennifer Kahle, Susan M. Catalano, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6251-6251
Open Access | Times Cited: 25
Multi-target drugs for Alzheimer's disease
Bengisu Turgutalp, Çağhan Kızıl
Trends in Pharmacological Sciences (2024) Vol. 45, Iss. 7, pp. 628-638
Closed Access | Times Cited: 14
A pharmacological toolkit for human microglia identifies Topoisomerase I inhibitors as immunomodulators for Alzheimer’s disease
Verena Haage, John F. Tuddenham, Natacha Comandante-Lou, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 8
Nerve growth factor receptor (Ngfr) induces neurogenic plasticity by suppressing reactive astroglial Lcn2/Slc22a17 signaling in Alzheimer’s disease
Tohid Siddiqui, Mehmet İlyas Coşacak, Stanislava Popova, et al.
npj Regenerative Medicine (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 16
Discovery of quinazolin-4(3H)-one derivatives as novel AChE inhibitors with anti-inflammatory activities
Ling Lv, Mireguli Maimaitiming, Yan Huang, et al.
European Journal of Medicinal Chemistry (2023) Vol. 254, pp. 115346-115346
Closed Access | Times Cited: 13
NCBP2-AS2 is a mitochondrial microprotein, regulates energy metabolism and neurogenesis, and is downregulated in Alzheimer's disease
Stanislava Popova, Prabesh Bhattarai, Elanur Yılmaz, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Lipoic acid scaffold applications in the design of multitarget-directed ligands against Alzheimer’s disease
Mohammad Amin Manavi, Mona Nourhashemi, Saeed Emami, et al.
Bioorganic Chemistry (2025) Vol. 157, pp. 108241-108241
Closed Access
Multitarget-Directed Carbamate and Carbamothioate Derivatives: Cholinesterase and Monoamine Oxidase Inhibition, Anti-Β-Amyloid (Aβ) Aggregation, Antioxidant and Blood–Brain Barrier Permeation Properties Against Alzheimer's Disease
Senel Teke Tuncel, Sule Erol Gunal, İlke Demir, et al.
(2025)
Closed Access
Design, synthesis and evaluation of novel L-tryptophan derivatives as multifunctional agents with cholinesterase inhibition, anti-β-amyloid aggregation, anti-inflammatory, antioxidant and neuroprotection properties against Alzheimer's disease
Haiyang Yu, Yinfang Chen, Huizhen Li, et al.
Bioorganic Chemistry (2025), pp. 108478-108478
Closed Access
Zebrafish as an Experimental and Preclinical Model for Alzheimer’s Disease
Prabesh Bhattarai, Bengisu Turgutalp, Çağhan Kızıl
ACS Chemical Neuroscience (2022) Vol. 13, Iss. 20, pp. 2939-2941
Closed Access | Times Cited: 16
Discovery of novel hybrids containing clioquinol−1-benzyl-1,2,3,6-tetrahydropyridine as multi-target-directed ligands (MTDLs) against Alzheimer's disease
Xinnan Li, Tiantian Li, Pengfei Zhang, et al.
European Journal of Medicinal Chemistry (2022) Vol. 244, pp. 114841-114841
Open Access | Times Cited: 16
ABCA7-dependent induction of neuropeptide Y is required for synaptic resilience in Alzheimer’s disease through BDNF/NGFR signaling
Hüseyin Tayran, Elanur Yılmaz, Prabesh Bhattarai, et al.
Cell Genomics (2024) Vol. 4, Iss. 9, pp. 100642-100642
Open Access | Times Cited: 3
Potential bioactive compounds and mechanisms of Fibraurea recisa Pierre for the treatment of Alzheimer’s disease analyzed by network pharmacology and molecular docking prediction
Shishuai Wang, Yixuan Ma, Yu‐Ping Huang, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 13
ABCA7-dependent Neuropeptide-Y signalling is a resilience mechanism required for synaptic integrity in Alzheimer’s disease
Hüseyin Tayran, Elanur Yılmaz, Prabesh Bhattarai, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Discovery of novel melatonin–mydroxyquinoline hybrids as multitarget strategies for Alzheimer’s disease therapy
Wei Wang, Tingting Pan, Rui Su, et al.
Frontiers in Chemistry (2024) Vol. 12
Open Access | Times Cited: 2
Mechanisms linking cerebrovascular dysfunction and tauopathy: Adding a layer of epiregulatory complexity
Yoon A. Kim, Marian Mellén, Çağhan Kızıl, et al.
British Journal of Pharmacology (2023) Vol. 181, Iss. 6, pp. 879-895
Closed Access | Times Cited: 5
Multi-Target-Directed Ligand Approach in Anti-Alzheimer’s Drug Discovery
Vaishali M. Patil, Neeraj Masand, Vertika Gautam, et al.
(2023), pp. 285-319
Closed Access | Times Cited: 2
Ngfr suppresses Lcn2/Slc22a17 signaling, induces neurogenesis and reduces amyloid pathology in the hippocampus of APP/PS1dE9 mouse
Tohid Siddiqui, Mehmet İlyas Coşacak, Stanislava Popova, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 4
A Pharmacological Toolkit for Human Microglia Identifies Topoisomerase I Inhibitors as Immunomodulators for Alzheimer's Disease
Verena Haage, John F. Tuddenham, Natacha Comandante-Lou, et al.
(2024)
Open Access
Lead Identification Through In Silico Studies: Targeting Acetylcholinesterase Enzyme Against Alzheimer’s Disease
Dhairiya Agarwal, Sumit Kumar, Ramesh Ambatwar, et al.
Central Nervous System Agents in Medicinal Chemistry (2024) Vol. 24, Iss. 2, pp. 219-242
Closed Access
Identification of Azelastine and Carvedilol as Cholinesterase Inhibitors via Structure‐Based Virtual Screening of FDA‐approved Drugs
Mohit Sharma, Shikha Thakur, Hemant R. Jadhav, et al.
ChemistrySelect (2023) Vol. 8, Iss. 28
Closed Access | Times Cited: 1
Page 1

Scroll to top